Increased Urinary Liver-Type Fatty Acid-Binding Protein Level Predicts Major Adverse Cardiovascular Events in Patients With Hypertension.

American Journal of Hypertension
Yousaku OkuboYasuki Kihara

Abstract

Urinary liver-type fatty acid-binding protein (L-FABP) has been known as a potential biomarker for acute kidney injury. It has also been suggested to have an effective predictive value for cardiovascular mortality in patients with diabetes or critically ill condition. Therefore, this study aimed to examine the ability of urinary L-FABP in predicting mid-term cardiovascular morbidity and mortality in patients with hypertension. Urinary L-FABP levels in stable outpatients without diabetes who were treated with antihypertensive drugs were measured, and a 5-year follow-up was planned. The primary end-point was a combination of acute heart failure requiring hospitalization, myocardial infarction, stroke, and cardiovascular death. The secondary end-point was kidney disease progression defined as a relative decline in the estimated glomerular filtration rate of ≥30% from the baseline. A total of 197 patients were recruited. Primary and secondary end-points occurred in 24 (12.2%) and 42 (21.3%) patients, respectively, during a median follow-up of 5.7 years. Patients with urinary L-FABP levels higher than the upper limit (8.4 µg/g creatinine) were more likely to reach the primary (30.43% vs. 9.77%; P = 0.003) and secondary end-points (5...Continue Reading

References

Mar 27, 2003·Journal of Hypertension·C M M LawesUNKNOWN Asia Pacific Cohort Studies Collaboration
Sep 24, 2004·The New England Journal of Medicine·Alan S GoChi-yuan Hsu
Dec 15, 2004·Archives of Internal Medicine·Peter W de LeeuwGilbert Wagener
Nov 18, 2005·Journal of the American Society of Nephrology : JASN·Masaomi Nangaku
Jul 25, 2006·Clinica Chimica Acta; International Journal of Clinical Chemistry·Atsuko Kamijo-IkemoriKenjiro Kimura
Apr 26, 2008·Annual Review of Nutrition·Judith Storch, Betina Corsico
Nov 21, 2008·American Journal of Physiology. Renal Physiology·Eisei NoiriTakeshi Sugaya
Mar 6, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Sadayoshi ItoTakefumi Mori
Apr 1, 2010·Kidney International·Blaithin A McMahon, Patrick Thomas Murray
Sep 30, 2010·Nature Reviews. Nephrology·Imari Mimura, Masaomi Nangaku
Jun 15, 2011·European Heart Journal·Kevin DammanRoberto Latini
Jan 25, 2012·The Annals of Thoracic Surgery·Daisuke KatagiriEisei Noiri
Apr 12, 2012·Clinical Journal of the American Society of Nephrology : CJASN·Mahboob RahmanUNKNOWN ALLHAT Collaborative Research Group
Nov 1, 2012·JAMA : the Journal of the American Medical Association·Stein I HallanUNKNOWN Chronic Kidney Disease Prognosis Consortium
Dec 12, 2012·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Paweena SusantitaphongBertrand L Jaber
Apr 20, 2013·Clinical Journal of the American Society of Nephrology : CJASN·Chirag R ParikhUNKNOWN TRIBE-AKI Consortium
Jun 4, 2013·Clinica Chimica Acta; International Journal of Clinical Chemistry·Atsuko Kamijo-IkemoriKenjiro Kimura
Jun 4, 2014·JAMA : the Journal of the American Medical Association·Josef CoreshAndrew S Levey
Dec 3, 2014·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Lesley A InkerAndrew S Levey
Dec 3, 2014·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Hiddo J Lambers HeerspinkLesley A Inker
Dec 3, 2014·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Tom GreeneAndrew S Levey

❮ Previous
Next ❯

Citations

Jul 23, 2020·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·T ShimoyamaK Kimura

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.